Arrowhead Research reported $33.05M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Ligand Pharmaceuticals USD 26.05M 20.68M Jun/2025
Merck USD 4.04B 261M Jun/2025
Moderna USD 175M 51M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
TG Therapeutics 134.02M 92.06M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025
Xencor USD 18.53M 2.34M Jun/2025